CLDX As of June 30, 2012, Celldex had approximately 58.8 million shares outstanding. Even if they floated an additional 15 million (to raise ~$100 million), that is still far well below the outstanding shares of 75% biotechs I follow. I'd be fine with that. I just don't want them to sign on shitty terms for '011.